Quick Answer
CalciMedica, Inc. reported Cash And Cash Equivalents At Carrying Value of $11.52 million for the year ending 2025.
- CalciMedica, Inc. showed an increase of +45.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CalciMedica, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $94.97 million | Q1 2021: $10.59 million | Q2 2021: $7.86 million | Q3 2021: $11.45 million | Q1 2022: $8.36 million | Q2 2022: $13.87 million | Q3 2022: $10.17 million | Q1 2023: $24.39 million | Q2 2023: $19.08 million | Q3 2023: $11.64 million | Q1 2024: $6.76 million | Q2 2024: $5.06 million | Q3 2024: $9.15 million | Q1 2025: $12.56 million | Q2 2025: $5.92 million | Q3 2025: $5.47 million.
- Over the full 7 years of available data (2019 to 2025), CalciMedica, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 27.4%.
- Historical annual values: Fiscal year 2025: $11.52 million | Fiscal year 2024: $7.94 million | Fiscal year 2023: $5.53 million | Fiscal year 2022: $1.33 million | Fiscal year 2021: $13.36 million | Fiscal year 2020: $33.42 million | Fiscal year 2019: $15.87 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: